[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.171.35. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 1983

Treatment of Gilles de la Tourette's Syndrome With Clonidine and Neuroleptics

Author Affiliations

From the Department of Psychiatry (Drs A. Shapiro and E. Shapiro) and the Tourette and Tic Laboratory and Clinic (Drs A. Shapiro and E. Shapiro and Ms Eisenkraft), Mount Sinai School of Medicine, New York.

Arch Gen Psychiatry. 1983;40(11):1235-1240. doi:10.1001/archpsyc.1983.01790100081011
Abstract

• In an open clinical trial of clonidine hydrochloride and neuroleptics in patients with Gilles de la Tourette's syndrome, neuroleptics resulted in greater improvement across the range of symptoms in a larger proportion of patients than did clonidine. A small subgroup of patients may have benefited from treatment with clonidine. Carefully controlled, randomized, and double-blind studies are necessary to resolve the divergent views about the effectiveness of clonidine in the treatment of Gilles de la Tourette's syndrome.

×